Breast Cancer Therapies

North East, USA

Short Summary

We are developing the first targeted therapy for Triple Negative Breast Cancer. It is the most aggressive type of breast cancer with no drugs currently available for its treatment and is an unmet need with a market size of $18.2 billion.

Highlights

  • First targeted therapy for Triple Negative Breast Cancer
  • Addresses an unmet need with market size of $18.2 Billion
  • Unique biomarker that is also an excellent drug target
  • Only one of its kind that works for all types of breast cancers
  • Exceptionally qualified team with over 100 years collective experience
Please note: Investing in early stage businesses involves risks, including illiquidity, lack of dividends, loss of investment and dilution, and it should be done only as part of a diversified portfolio. This platform is targeted solely at investors who are sufficiently sophisticated to understand these risks and make their own investment decisions. This information has not been approved as a financial promotion, and you must carry out your own due diligence.

Overview

Target
US$1,000,000
Minimum
US$100,000
Investment Raised
N/A
Previous Rounds US$450,000
Stage Pre-Startup/R&D
Investor Role Any

Want to pitch on Angel Investment Network?

It’s easy to create a pitch using our online form. Your pitch can be in front of our 195,403 investors before you know it.

Create New Account
Already have an account?

Similar Projects

Featured
6% raised

Trillum Eye Care Pre-IPO

South East, USA

Join this international health care group expand clinics in North America. Convertible Note pays 10% interest which converts into Stock pre-IPO. Company is targeting an IPO in the US.

US$ 1,500,000

Target

US$ 5,000

Min per Investor

Global Pro
0% raised

Hemp with a Heart

West, USA

Our organic cannabinoid extracts have been chosen by Kevin Harrington to produce our very own DRTV commercial featuring our unique difference in the marketplace. At NOHI, we support complete healing through education, co-creation, and empowerment.

US$ 125,000

Target

US$ 500

Min per Investor

Global Pro
0% raised

New Rotator Cuff Product

North East, USA

We have issued patents for a new breakthrough technology that will greatly improve the standard of care for rotator cuff tears and at the same time reduce medical spending. This investment will bring this new product to the FDA for approval.

US$ 1,500,000

Target

US$ 5,000

Min per Investor

load one similar proposal